➡️NDEWS Hotspot Alerts (n=26) January 26 – February 1, 2023: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
➡️Alert from the Web Monitoring Team: Online mentions of Tucibi
(2/2)
👉Weekly Briefing Issue 118 is out now!👉🔗: https://bit.ly/3X7qNuO🔸Featuring an NDEWS Spotlight🔦on nitazene analogs
➡️Quotes from NDEWS Sentinel Site Directors regarding nitazene analogs in their area
(1/2)
Xylazine is spreading all over the USA. Approximately 1 year ago, we started seeing xylazine related posts on Reddit primarily from people in the North East. Thanks to
Weekly Briefing Issue 117 is out now!: https://bit.ly/3kH0oX7Featuring an NDEWS Spotlight on xylazine
Report from the Web Monitoring Team: Online mentions of xylazine
Quotes from NDEWS Sentinel Site Directors regarding xylazine's impact in their area
👉Weekly Briefing Issue 117 is out now!👉🔗: https://bit.ly/3kH0oX7🔹Featuring an NDEWS Spotlight🔦 on xylazine
➡️Report from the Web Monitoring Team: Online mentions of xylazine
➡️Quotes from NDEWS Sentinel Site Directors regarding xylazine's impact in their area
➡️Q&A with Nathan Sackett, MD, MS, Director, Center for Novel Therapeutics in Addiction Psychiatry Department of Psychiatry and Behavioral Sciences, University of Washington
(3/3)
➡️Quote from Devika Bhatia, MD, Instructor, Child and Adolescent Psychiatry, University of Colorado Anschutz Medical Campus, Denver, CO, NDEWS Sentinel Site Director
(2/3)
👉Weekly Briefing Issue 116 is out now!👉🔗: https://bit.ly/3ZNFvd4🔹Featuring an NDEWS Spotlight 🔦on changing policies surrounding psychedelics
➡️Report from the Web Monitoring Team: Online mentions of psilocybin
(1/3)
👉Weekly Briefing Issue 115 is out now!👉🔗: https://bit.ly/3k2uZhx🔹Featuring original NDEWS contributions:
➡️Report from the Web Monitoring Team: Online mentions of Ozempic
➡️Ozempic misuse responses from our Sentinel Sites
(1/2)
Methamphetamine manufacturing has changed across Canada & the U.S. These new processes may be accelerating the deterioration in the mental health of people who use #methamphetamines. Learn more in the new #CCENDU bulletin on #stimulants: http://bitly.ws/xTTa
👉Weekly Briefing Issue 114 is out now!👉🔗: https://bit.ly/3CtGQeR🔹Featuring original NDEWS contributions:
➡️NDEWS Hotspot Alerts December 29 – January 4: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
(1/2)
To address the overdose crisis in the United States, the #NIH has established a research network that will test #harmreduction strategies in different community settings to inform efforts to help save lives.
🗣️Have you heard of tianeptine?🗣️🔸If you have any data or information regarding the drug tianeptine fill out the submission form below!
🔗: https://bit.ly/3Pz0Q5p
👉Weekly Briefing Issue 113 is out now!👉🔗: https://bit.ly/3PBvjj1🔸Featuring original NDEWS contributions:
➡️CCENDU x NDEWS Bulletin
➡️Rapid Street Reporting: Substance use in the past 12 months, Charleston, SC
(1/2)
📄Characteristics of poisonings involving ketamine in the US, 2019–2021
▪️ The study found that poisonings involving ketamine, although still rare, increased 81% from 2019 Quarter 1 through 2021 Quarter 4.
🔗: https://bit.ly/3W26Lls
➡️NDEWS Rapid Street Reporting: Rates of past 12-month reported ketamine use by order of visit (November 2021–November 2022)
➡️NDEWS Hotspot Alerts December 1–7, 2022: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
👉Weekly Briefing Issue 112 is out now!👉🔗: https://bit.ly/3W26Lls🔹Featuring original NDEWS contributions:
➡️Characteristics of poisonings involving ketamine in the US, 2019–2021
➡️Alert from the NDEWS Web Monitoring Team: Increases in online mentions of FXE
(1/2)
Our new paper: #ketamine related poisonings in the US increased through 2021 but are still somewhat rare. Not the most dangerous drug but something we need to keep an eye on. Not to be mixed with alcohol or GHB